We describe a combined gas-chromatographic massspectrometric method for determination of theophylline in whole blood. With use of a probability-based matching approach, the extensive gas-chromatographic interference did not affect mass-spectrometric quantitation of theophylline. Concentrations expected and found were linearly related from 1 to 60 mg/liter; the run-to-run coefficient of variation was <8%, within-run <6%. Some other xanthines and drugs frequently co-administered with theaphylline did not affect results. Only 0.2 ml of blood is required, which makes the procedure useful for monitoring theophylline in newborns and pediatric populations.
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pediatric chemistry #{149} probabilitybased matching #{149} monitoring therapy #{149} drug assay Theophylline (1,3-dimethylxanthine) is an effective bronchodilator, used frequently in treating obstructive lung disease (1) and, more recently, in treating apnea in newborns (2) . The risk of toxicity associated with the use of this drug as a bronchodilator is well recognized (1, 3) , and it is generally recommended that its concentrations be monitored in the blood. Of the many methods used for measuring theophylline in body fluids (4-15), gas chromatography is probably the most common (6) (7) (8) (9) (10) For correlation studies, we used the gas- 
Materials and Methods
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Results
Figure 1 compares the gas chromatogram
from a 1-il injection of the mixture of derivatized standards (1 or 1 g/liter) used to calibrate the mass spectrometer with that from a 1-zl injection of a derivatized extract of 2 ml of blood to which 20 sg each of theophylline and 3-isobutyl-1-methylxanthine had been added. Despite the considerable chromatographic interference, the run-to-run coefficient of variation (n = 7, = 10 mg/liter) for the ratio of quantities for theophylline vs. 3-isobutyl-1-methylxanthine for extracts of blood standards and patients' specimens was found to be 7.4% and the within-run CV to be 5.6% (n = 10, = 10 mg/liter).
A plot of computed theophylline values vs. the amount of theophylline actually added to blood ( mass-spectral screening for theophylline at all retention times, and mass-spectral screening for theophylline with retention-time screening (e.g., only scanning for theophylline within ±5% of its absolute retention time). To check the accuracy of this procedure, we compared results from split patients' samples analyzed as above and by the gas-chromatographic procedure of Sheehan and Haythorn 
Discussion
Our data illustrate the main advantage of the probability-based matching quantitation approach vs. the usual technique of integrating the peak on the chromatogram from the flame ionization or total ion technique. The former approach allows theophylline to be accurately and reproducibly quantitated in spite of considerable chromatographic interference, whereas under these conditions theophylline could not be quantitated by either gas chromatography alone or by the usual gas chromatography/mass spectrometry approaches. Standard mass-fragmentographic techniques could of course be used. In general, however, standard mass-fragmentographic analyses require rather elaborate extraction schemes to assure removal of possible contaminants.
Because it considers the relative ratios as well as the intensities of several ions simultaneously (up to 17 in this system), probability-based matching quantitation is much less affected by mass spectral contamination.
Only when the contaminant spectrum has significant intensity at most or all of the masses used for identification of the compound of interest does this usually become a problem.
By combining a judicious choice of masses with retention-time screening, spectral interference is usually insignificant, as is dramatically illustrated in In their study recommending the use of theophylline in the treatment of apnea in newborns, Shannon et a!.
(2) drew 4 ml of venous blood for drug-concentration monitoring 2 h after every oral dose (four times a day). At this rate, most infants would very rapidly become anemic. Most other gas-chromatographic procedures (but not all) require at least 1 ml of blood or serum (usually serum, therefore 2 ml of blood), and are therefore not much better than the method used by Shannon et al. That the procedure we describe can be readily done on only 0.2 ml of blood makes it ideally suited for monitoring theophylline in newborns. We believe the sensitivity (although reported as 1 mg/liter of blood, more sensitivity could easily be obtained by injecting more material or using smaller volumes of derivatizing reagents or both), the speed of analysis (<30 mm turnaround time per specimen, including extraction and derivitization), the precision and linearity, and the microcapability of this procedure afford it definite advantages over the conventional gaschromatographic methods for determining theophylline in blood or serum.
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